ArticleBMC plant biology2026
Enhancement of rosmarinic acid biosynthesis in Ocimum basilicum L. via melatonin-loaded nanoparticles: insights into enzymatic activity and gene expression.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to synthesize melatonin laoded chitosan nanoparticles (MEL NPs) and assess its effects on the production of bioactive metabolites, antioxidant activity and gene expression in O. basilicum culture.
resultsOur results showed that the total phenolic (TPC) and total flavonoid (TFC) content of basil leaves treated with melatonin (MEL) and MEL NPs at 5, 10, and 20 μm was significantly increased, with the rosmarinic acid content also being enhanced. Treatment with 10 µM MEL NPs induced the most pronounced enhancement in total phenolic content (TPC) and total flavonoid content (TFC), reaching 3.48 and 3.79- fold, respectively, compared with the control. meanwhile, the same treatment resulted in the maximum accumulation of rosmarinic acid (RA), 19.73 mg g⁻¹ FW. Furthermore, the application of MEL NPs or melatonin markedly stimulated the phenylprpanoid pathway in basil leaves, as evidenced by the enhanced activities of tyrosine aminotransferase (TAT) and phenylalanine ammonia-lyase (PAL). This enzymatic stimulation was accompanied by significant transcriptional activation of key pathway genes. Notably, basil leaves treated with 10 µM MEL NPs showed pronounced upregulation of 4-coumarate: CoA ligase (4CL) and Hydroxyphenylpyruvate reductase (HPPR) transcript with expression levels increasing by 3.45- and 5.47-fold, respectively, compared with the untreated control.
conclusionThe study concluded that nano encapsulated melatonin at 10 µM was the most effective elicitor for stimulating rosmarinic acid biosynthesis by coordinating transcriptional activation of key biosynthetic genes and enhancing tha activities of related enzymes in basil tissue culture. This is due to its stability and targeted delivery compared to conventional melatonin in large-scale Ocimum basilicum L. plant cultivation as a resource for food and pharmaceutical industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.